Inflammation-mediated damage in progressing lacunar infarctions -: A potential therapeutic target

被引:212
作者
Castellanos, M
Castillo, J
García, MM
Leira, R
Serena, J
Chamorro, A
Dávalos, A
机构
[1] Hosp Univ Josep Trueta, Secc Neurol, Giron 17007, Spain
[2] Hosp Univ Josep Trueta, Biostat Unit, Giron 17007, Spain
[3] Hosp Clin Univ, Neurol Serv, Barcelona, Spain
[4] Hosp Clin Univ, Neurol Serv, Santiago De Compostela, Spain
关键词
cytokines; inflammation; lacunar infarction; stroke outcome;
D O I
10.1161/hs0402.105339
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The mechanisms underlying neurological deterioration in patients with lacunar infarction are not completely understood. In this study, we sought to investigate the role of proinflammatory molecules in the early worsening and outcome of acute lacunar stroke. Methods-We performed a secondary analysis of 113 consecutive patients with lacunar infarction included within the first 24 hours of the onset of symptoms in a previous study aimed at investigating clinical and biochemical factors of early neurological deterioration (END). END was defined as a fall of greater than or equal to1 points in the motor items of Canadian Stroke Scale between inclusion and 48 hours. Poor outcome at 3 months was considered death or Barthel Index <85. Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and intercellular adhesion molecule-1 (ICAM-1) were determined by enzyme-linked immunoabsorbent assay in blood samples obtained on admission. Results-END was recorded in 27 patients (23.9%); poor outcome was noted in 26 (23%). Median (quartiles) concentrations in plasma of TNF-alpha [16.5 pg/mL (13.7 and 21.2 pg/mL) versus 7.5 pg/mL (6.2 and 9.0 pg/mL)], IL-6 [28.8 pg/mL (22.5 and 35.7 pg/mL) versus 11.5 pg/mL (8.5 and 16.2 pg/mL)], and ICAM-1 [285 pg/mL (219 and 315 pg/mL) versus 158 pg/mL (137 and 187 pg/mL)] were significantly higher in patients who had END than in those with nonprogressing strokes (P<0.001). Significant differences were also observed between patients with poor and good outcome at 3 months. Logistic regression analysis after adjustment for potential confounders showed that TNF-alpha > 14 pg/mL and ICAM-1 >208 pg/mL were independently associated with both END (OR, 511; 95% CI, 17 to 4937; P<0.001; and OR, 315; 95% CI, 17 to 5748; P<0.001, respectively) and poor outcome at 3 months (OR, 3.0; 95% CI, 1.0 to 8.5; P=0.042; and OR, 4.2; 95% CI, 1.3 to 13.6; P<0.015, respectively). Conclusions-High concentrations of inflammatory markers in blood are associated with END and poor functional outcome in lacunar infarctions. These findings suggest that inflammation contributes to brain injury in lacunar stroke.
引用
收藏
页码:982 / 987
页数:6
相关论文
共 49 条
[1]   Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage [J].
Akopov, SE ;
Simonian, NA ;
Grigorian, GS .
STROKE, 1996, 27 (10) :1739-1743
[2]   THE NATURAL-HISTORY OF LACUNAR INFARCTION - THE OXFORDSHIRE COMMUNITY STROKE PROJECT [J].
BAMFORD, J ;
SANDERCOCK, P ;
JONES, L ;
WARLOW, C .
STROKE, 1987, 18 (03) :545-551
[3]   Tumor necrosis factor-alpha - A mediator of focal ischemic brain injury [J].
Barone, FC ;
Arvin, B ;
White, RF ;
Miller, A ;
Webb, CL ;
Willette, RN ;
Lysko, PG ;
Feuerstein, GZ .
STROKE, 1997, 28 (06) :1233-1244
[4]   A longitudinal prospective study of soluble adhesion molecules in acute stroke [J].
Bitsch, A ;
Klene, W ;
Murtada, L ;
Prange, H ;
Rieckmann, P .
STROKE, 1998, 29 (10) :2129-2135
[5]  
CASTILLO J, 2000, CEREBROVASC DIS, V10, P85
[6]  
CECHETTO DF, 2001, PROG BRAIN RES, V132, P401
[7]   TUMOR-NECROSIS-FACTOR-ALPHA POTENTIATES GLUTAMATE NEUROTOXICITY IN HUMAN FETAL BRAIN-CELL CULTURES [J].
CHAO, CC ;
HU, SX .
DEVELOPMENTAL NEUROSCIENCE, 1994, 16 (3-4) :172-179
[8]   CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 LEVELS AND NEUTROPHIL ADHESION IN STROKE [J].
CLARK, WM ;
COULL, BM ;
BRILEY, DP ;
MAINOLFI, E ;
ROTHLEIN, R .
JOURNAL OF NEUROIMMUNOLOGY, 1993, 44 (01) :123-126
[9]  
Clark WM, 1996, STROKE, V27, P112
[10]   THE CANADIAN NEUROLOGICAL SCALE - VALIDATION AND RELIABILITY ASSESSMENT [J].
COTE, R ;
BATTISTA, RN ;
WOLFSON, C ;
BOUCHER, J ;
ADAM, J ;
HACHINSKI, V .
NEUROLOGY, 1989, 39 (05) :638-643